GSK3B and early-onset autosomal dominant Alzheimer disease: In various sterile inflammatory models such as collagen-induced arthritis, ischemia-reperfusion injury, streptozotocin-induced diabetes, and Alzheimer’s disease, GSK3β activation was induced and administration of GSK3β inhibitors effectively reduced inflammatory response [62].